跳至主要内容
临床试验/NCT00306462
NCT00306462终止不适用

Randomized Double-Blinded Trial of Magnesium Sulfate Tocolysis Versus Nifedipine Tocolysis in Women With Preterm Labor Between 24 to 32 6/7 Weeks' Gestation

University of Cincinnati1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2006年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
33
试验地点
1
主要终点
Delivery <37 weeks' gestation, Delivery <34 weeks' gestation, Delivery <32 weeks' gestation

研究概览

简要总结

Primary Hypothesis:

Acute tocolysis (48 hours) using oral nifedipine is more effective than intravenous magnesium sulfate in prolonging pregnancy in women with preterm labor with intact membranes between 24 and 32 6/7 weeks' gestation.

详细描述

Primary Objective:

To compare the efficacy of oral nifedipine versus IV magnesium sulfate on the rate of preterm delivery at <37 weeks in women with preterm labor between 24 and 32 6/7 weeks gestation.

Secondary Objective:

  1. To compare maternal side effects between the two tocolytic agents
  2. To compare neonatal morbidities between the two study groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
15 Years 至 50 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Women in preterm labor between 24 to 32 6/7 weeks' gestation with intact membranes with an age range of 15 to 50 years old.

排除标准

  • Cervical dilatation of ≥ 6 cm
  • Maternal contraindication to tocolysis
  • Known fetal anomalies
  • Suspected chorioamnionitis
  • Nonreassuring fetal heart tracing
  • Vaginal bleeding due to placenta previa or abruptio placenta
  • Preterm premature rupture of membranes
  • Prolapsed membranes
  • Human immunodeficiency virus positive
  • Multiple gestation
  • Patients on procardia within 24 hours of po intake
  • Magnesium sulfate tocolysis prior to randomization
  • Patient refusal

研究组 & 干预措施

1

Active Comparator

Intravenous magnesium sulfate or placebo

干预措施: Magnesium sulfate (Drug)

2

Active Comparator

Oral nifedipine or placebo

干预措施: Oral Nifedipine or placebo (Drug)

结局指标

主要结局

Delivery <37 weeks' gestation, Delivery <34 weeks' gestation, Delivery <32 weeks' gestation

时间窗: 4 years

次要结局

  • Maternal complications associated with each drugs. Neonatal morbidities associated with prematurity(4 years and 9 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验